Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Tests myoelectric biofeedback to help arm movement after stroke

Tests myoelectric biofeedback with rehabilitation training in older adults with stroke-related arm weakness.

Key facts

Who runs it
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Where
Yiwu, ChinaSee the site
Trial code
Registry title
Effects of Myoelectric Biofeedback on Upper Limb Function in Post-stroke Patients
Status
Recruiting
People taking part
80 people, planned
Started
1 Jul 2024
Planned end
1 Jun 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Observation Group
Record updated
17 February 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for older adults with weakness on one side after a stroke caused by a blocked brain artery. It tests muscle-signal biofeedback therapy for arm function.

Age
65 to 80 years
Sex
All sexes can join.
Disease stage
Diagnosed stroke (cerebral infarction) with weakness on one side of the body.

Main reasons for not taking part

  • Other major heart or blood vessel diseases
  • Skin allergies
  • Severe consciousness disorders, severe dementia or speech disorders that make it hard to communicate
  • Cannot cooperate as required or poor compliance
  • Taking part in other clinical trials

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Subject volunteered to participate in the experiment and signed informed consent
  • Age ≥ 65 years old, no gender limit
  • Diagnosis of stroke patients
  • No other major cardiovascular diseases

Who cannot take part

  • Subjects with skin allergies
  • People with severe consciousness disorders, severe dementia, speech disorders, etc. who are unable to communicate and describe the disease
  • Subject's poor compliance
  • Those who do not meet the criteria for diagnosis and inclusion
  • can not cooperate as required, poor compliance
  • participants in other clinical trials

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 65 and 80 years old?

Where in China

  • Yinkai ChengYiwu, ChinaContact: Yinkai ChengTaking people

About the trial

What the trial wants to find out

The purpose of this clinical trial is to investigate the effect of myoelectric biofeedback therapy on upper limb function in elderly patients with cerebral infarction, and to analyze the adjustment of stroke condition and quality of life.The main questions it aims to answer are:

Read full original descriptionShow less

1. Does myoelectric biofeedback therapy promote the restoration of upper limb function in elderly patients with cerebral infarction? 2. What medical problems do participants have with myoelectric biofeedback therapy?

The 2 groups in the trial

  • control groupNo study treatment, for comparison

    Comprehensive rehabilitation treatment in control group

  • Observation GroupTreatment being tested

    The observation group carried out myoelectric biofeedback therapy on the basis of the control group

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Objective To Investigate the Effect of Myoelectric Biofeedback Therapy Combined With Comprehensive Rehabilitation Training on Upper Extremity Motor Function in Elderly Patients With Hemiplegia With Cerebral Infarction
Plain-language title
Tests myoelectric biofeedback to help arm movement after strokeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06443008, who can take part
Record updated
17 February 2025